(Pro)renin receptors and angiotensin converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in human aortic valve stenosis

Atherosclerosis

Volumn 216, Issue 1, 2011, Pages 35-43

  Peltonen, Tuomas ^a   Näpänkangas, Juha ^b   Ohtonen, Pasi ^b   Aro, Jani ^a   Peltonen, Jenni ^a   Soini, Ylermi ^c   Juvonen, Tatu ^b   Satta, Jari ^b   Ruskoaho, Heikki ^a   Taskinen, Panu ^b  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

(Pro)renin receptor; Angiotensin converting enzyme; Calcification; Fibrosis; Mas receptor

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAS RECEPTOR; MEMBRANE RECEPTOR; MESSENGER RNA; PRORENIN RECEPTOR; RENIN; UNCLASSIFIED DRUG;

ADULT; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STROMA CELL; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; CALCINOSIS; CASE-CONTROL STUDIES; FEMALE; FIBROSIS; FINLAND; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDYL-DIPEPTIDASE A; PROTO-ONCOGENE PROTEINS; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RENIN; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VACUOLAR PROTON-TRANSLOCATING ATPASES; YOUNG ADULT;

EID: 79955541355     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.01.018     Document Type: Article

References (31)

1. Otto C.M., Lind B.K., Kitzman D.W., Gersh B.J., Siscovick D.S. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999, 341:142-147.
2. Helske S., Kupari M., Lindstedt K.A., Kovanen P.T. Aortic valve stenosis: an active atheroinflammatory process. Curr Opin Lipidol 2007, 18:483-491.
3. Akat K., Borggrefe M., Kaden J.J. Aotic valve calcification: basic science to clinical practice. Heart 2009, 95:616-623.
4. Paul M., Poyan Mehr A., Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 2006, 86:747-803.
5. Bader M. Tissue renin-angiotensin-aldosterone systems: targets for pharmacological therapy. Annu Rev Pharmacol Toxicol 2010, 50:439-465.
6. O'Brien K.D., Shavelle D.M., Caulfield M.T., et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 2002, 106:2224-2230.
7. Helske S., Lindstedt K.A., Laine M., et al. Induction of local angiotensin II-producing systems in stenotic aortic valves. J Am Coll Cardiol 2004, 44:1859-1866.
8. Helske S., Syvaranta S., Kupari M., et al. Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves. Eur Heart J 2006, 27:1495-1504.
9. Donoghue M., Hsieh F., Baronas E., et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000, 87:E1-E9.
10. Santos R.A., Simoes de Silva A.C., Maric C., et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 2003, 100:8258-8263.
11. Ferrario C.M., Trask A.J., Jessup J.A. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 2005, 289:H2281-H2290.
12. Ferrario C.M. New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism. Hypertension 2010, 55:445-452.
13. Nguyen G., Delarue F., Burckle C., Bouzhir L., Giller T., Sraer J.D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002, 109:1417-1427.
14. Nguyen G., Danser A.H. Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents. Exp Physiol 2008, 93:557-563.
15. Funke-Kaiser H., Zollmann F.S., Schefe J.H., Unger T. Signal transduction of the (pro)renin receptor as a novel therapeutic target for preventing end-organ damage. Hypertens Res 2010, 33:98-104.
16. Nguyen G., Muller D.N. The biology of the (pro)renin receptor. J Am Soc Nephrol 2010, 21:18-23.
17. Peltonen T.O., Taskinen P., Soini Y., et al. Distinct downregulation of C-type natriuretic peptide system in human aortic valve stenosis. Circulation 2007, 116:1283-1289.
18. Lachenbruch P.A. Analysis of data with excess zeros. Stat Methods Med Res 2002, 11:297-302.
19. Satofuka S., Ichihara A., Nagai N., et al. (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system. Am J Pathol 2008, 173:1911-1918.
20. Uraoka M., Ikeda K., Nakagawa Y., et al. Prorenin induces ERK activation in endothelial cells to enhance neovascularization independently of the renin-angiotensin system. Biochem Biophys Res Commun 2009, 390:1202-1207.
21. Helske S., Laine M., Kupari M., et al. Increased expression of profibrotic neutral endopeptidase and bradykinin type 1 receptors in stenotic aortic valves. Eur Heart J 2007, 28:1894-1903.
22. Machado R.D., Santos R.A., Andrade S.P. Mechanisms of angiotensin-(1-7)-induced inhibition of angiogenesis. Am J Physiol Regul Integr Comp Physiol 2001, 280:R994-R1000.
23. Sampaio W.O., Henrique de Castro C., Santos R.A., Schiffrin E.L., Touyz R.M. Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension 2007, 50:1093-1098.
24. Kostenis E., Milligan G., Christopoulos A., et al. G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation 2005, 111:1806-1813.
25. Alenina N., Xu P., Rentzsch B., Patkin E.L., Bader M. Genetically altered animal models for Mas and angiotensin-(1-7). Exp Physiol 2008, 93:528-537.
26. Sampaio W.O., Souza dos Santos R.A., Faria-Silva R., da Mata Machado L.T., Schiffrin E.L., Touyz R.M. Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 2007, 49:185-192.
27. Gallagher P.E., Ferrario C.M., Tallant E.A. Regulation of ACE2 in cardiac myocytes and fibroblasts. Am J Physiol Heart Circ Physiol 2008, 295:H2373-H2379.
28. A-receptor levels in human aortic valve stenosis. Eur Heart J 2009, 30:242-249.
29. Rajamannan N.M., Subramaniam M., Springett M., et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 2002, 105:2660-2665.
30. Rajamannan N.M., Subramaniam M., Caira F., Stock S.R., Spelsberg T.C. Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via Lrp5 receptor pathway. Circulation 2005, 112:I229-1234.
31. Cawley Otto. Prevention of calcific aortic valve stenosis - fact or fiction?. Ann Med 2009, 41:100-108.